loadpatents
name:-0.018118143081665
name:-0.0069639682769775
name:-0.002655029296875
Medof; M. Edward Patent Filings

Medof; M. Edward

Patent Applications and Registrations

Patent applications and USPTO patent grants for Medof; M. Edward.The latest application filed is for "method for inhibiting platelet derived growth factor signaling with c3ar or c5ar antibodies".

Company Profile
2.10.16
  • Medof; M. Edward - Pepper Pike OH
  • Medof; M. Edward - Cleveland OH
  • Medof; M. Edward - Moreland Hills OH
  • Medof; M. Edward - Pepperpike OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES
App 20220185872 - Medof; M. Edward ;   et al.
2022-06-16
Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
Grant 11,130,801 - Medof , et al. September 28, 2
2021-09-28
Compositions And Methods Of Treating A T Cell Mediated Disorder
App 20210275585 - Medof; M. Edward ;   et al.
2021-09-09
Compositions and methods of treating a T cell mediated disorder
Grant 10,933,093 - Medof , et al. March 2, 2
2021-03-02
Compositions And Methods Of Promoting Wound Healing
App 20200062855 - Medof; M. Edward ;   et al.
2020-02-27
Compositions And Methods For Modulating Toll Like Receptor Signal
App 20180256646 - Medof; M. Edward ;   et al.
2018-09-13
Compositions And Methods Of Treating A T Cell Mediated Disorder
App 20180228843 - Medof; M. Edward ;   et al.
2018-08-16
Compositions and methods of treating T cell mediated disorder
Grant 9,937,206 - Medof , et al. April 10, 2
2018-04-10
Method For Treating Disorders Related To Complement Activation
App 20170189366 - Medof; M. Edward ;   et al.
2017-07-06
Method Of Treating T Cell Mediated Disorders
App 20170027861 - Medof; M. Edward ;   et al.
2017-02-02
Compositions And Methods Of Treating T Cell Mediated Disorder
App 20170014451 - Medof; M. Edward ;   et al.
2017-01-19
Compositions And Methods Of Modulating B Cell Response
App 20160362482 - Medof; M. Edward
2016-12-15
Compositions and methods of treating T cell mediated disorder
Grant 9,290,736 - Medof , et al. March 22, 2
2016-03-22
Method Of Treating Cancer
App 20150299300 - Medof; M. Edward ;   et al.
2015-10-22
Method of treating cancer
Grant 8,940,299 - Medof , et al. January 27, 2
2015-01-27
Hybrid and chimeric polypeptides that regulate activation of complement
Grant 8,932,601 - Medof , et al. January 13, 2
2015-01-13
Compositions And Method Of Modulating Growth Factor Function
App 20120315279 - Medof; M. Edward ;   et al.
2012-12-13
Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement
App 20120226020 - Medof; M. Edward ;   et al.
2012-09-06
Compositions And Methods Of Treating T Cell Mediated Disorder
App 20120219566 - Medof; M. Edward ;   et al.
2012-08-30
Method Of Treating T Cell Mediated Disorders
App 20110182910 - Medof; M. Edward ;   et al.
2011-07-28
Method Of Treating Cancer
App 20110135656 - Medof; M. Edward ;   et al.
2011-06-09
Method For Treating Disorders Related To Complement Activation
App 20100063146 - Medof; M. Edward ;   et al.
2010-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed